Kura Oncology (KURA) Interest & Investment Income (2015 - 2026)
Kura Oncology (KURA) recorded Interest & Investment Income of $5.03 million in Q2 2026, down 27.4% from $6.94 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Interest & Investment Income (2015 - 2026) Analysis & Trends
On a TTM basis, Kura Oncology's Interest & Investment Income came in at $25.67 million as of Jun 30, 2026, down 2.6% year-over-year; for FY2025, it came in at $26.77 million, up 17.2% from FY2024.
- Annual Interest & Investment Income has increased for four straight years, with a five-year compound annual growth rate of 56.5% (FY2020 to FY2025).
- Across earlier years, Interest & Investment Income came in at $22.85 million in FY2024 (+55.2%), $14.72 million in FY2023 (+246.1%), $4.25 million in FY2022 (+252.7%) and $1.21 million in FY2021 (-57.7%).
- The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q4 2023.
- On a year-over-year basis, Interest & Investment Income rose in four of the last six quarters, with growth averaging 13.0%.
- Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 769.6% in Q1 2023, against a decline of 45.5% in Q3 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kura Oncology | 947.36 Mn | 947.36 Mn | 20.63 Mn | 5.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.03 Mn |
| Mar 31, 2026 | 5.83 Mn |
| Jun 30, 2025 | 6.94 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 5.66 Mn |
| Sep 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 5.97 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 564,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 311,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 310,000.00 |
API Access
Kura Oncology Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();